Novel Radiotracer May Serve as Valuable Diagnostic Biomarker For Supranuclear Palsy
July 15th 2020The 18F-PI-2620 radiotracer’s positive effect on diagnosing and differentiating patients with suspected progressive supranuclear palsy leaves questions about its potential as a PSP progression biomarker.
Central Vein Sign: Redefining MS Diagnostic Criteria
July 13th 2020In part 2 of this interview, Daniel Ontaneda, MD, PhD, the co-principal investigator of the CAVS-MS study, describes the long-term goals of the study and how the central vein sign will be incorporated into standard diagnostic criteria for multiple sclerosis.
Miller School Plays Pivotal Role in Securing National Alzheimer's Disease Research Center
July 13th 2020The University of Miami Miller School of Medicine designated as 1 of the 31 centers of excellence by the National Institute of Aging and will play a huge role in the 1Florida Alzheimer's Disease Research Center.
Daniel Claassen, MD, MS: Selective Knock-Downs in Huntington Disease
July 8th 2020The associate professor of neurology at Vanderbilt University Medical Center spoke to the findings of a recent study in Huntington disease that assessed the feasibility of selectively knocking down mutant protein expression.